A new antigen gene of Schistosoma japonicum: Screening, cloning, expression and immunization in mice

Progress in Biochemistry and Biophysics

Volumn 32, Issue 4, 2005, Pages 331-337

  Chen, Li Yu ^a   Yi, Xin Yuan ^a   Zeng, Xian Fang ^a   Cai, Chun ^a   McReynolds, L ^b  

^a Central South University   (China)

^b NEW ENGLAND BIOLABS   (United States)

Author keywords

Female adult worm; Immunization; Immunoscreening; Schistosoma japonicum; Sj F1

Indexed keywords

CHITOSAN; COMPLEMENTARY DNA; DNA VACCINE; FREUND ADJUVANT; HYBRID PROTEIN; INTEIN; INTEIN 2; PRIMER DNA; RECOMBINANT ANTIGEN; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EUKARYOTIC CELL; EXPRESSION VECTOR; IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; LIVER; LOW TEMPERATURE; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROKARYOTIC CELL; PROVOCATION TEST; RABBIT; RECOMBINANT PLASMID; RESTRICTION MAPPING; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SERUM; SOLUBILITY; VACCINATION; WESTERN BLOTTING; WORM EGG;

ANIMALIA; ESCHERICHIA COLI; EUKARYOTA; ORYCTOLAGUS CUNICULUS; PROKARYOTA; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 21044431952     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Richter D, Incani R N, Harn D A. Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect Immun, 1993, 61 (7): 3003-3011
2. Zhou J C, Yi X Y, Zeng X F, et al. Immunoscreening of Schistosoma japonicum egg cDNA library. Chin J Parasitol Parasitic Dis, 1998, 16 (2): 176-180
3. Rao K V, He Y X, Kalyanasundaram R. Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential. Clin Diagn Lab Immunol, 2003, 10 (4): 536-541
4. McManus D P, Wong J Y, Zhou J, et al. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes. Vaccine, 2001, 20 (5-6): 870-878
5. R Zhu Y, Si J, Ham D A, et al. The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase. Southeast Asian J Trop Med Public Health, 2002, 33 (2): 207-213
6. Da'dara A A, Skelly P J, Wang M M, et al. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine, 2001, 20 (3-4): 359-369
7. Ramos C R, Figueredo R C, Pertinhez T A, et al. Gene structure and M20T polymorphism of the Schistosoma mansoni Sm14 fatty acid-binding protein, molecular, functioanl, and immunoprotection analysis. J Biol Chem, 2003, 278 (15): 12745-12751
8. Yuki Y, Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol, 2003, 13 (5): 293-310
9. van der Lubber I M, Verhoef J C, Borchard G, et al. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci, 2001, 14 (3): 201-207
10. Westerink M A, Smithson S L, Srivastava N, et al. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine, 2001, 20 (5-6): 711-723
11. Le Buanec H, Vetu C, Lachgar A, et al. Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes. Biomed Pharmacother, 2001, 55 (6): 316-320
12. in C T, Hung C F, Juang J, et al. Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles. Mol Ther, 2003, 8 (4): 559-566
13. Gherardi M M, Nájera J L, Pérez-Jiménez E, et al. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes. J Virol, 2003, 77 (12): 7048-7057
14. + T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J Immunol, 2004, 172 (5): 3094-3100
15. Coban C, Philipp M T, Purcell J E, et al. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect Immun, 2004, 72 (1): 253-259
16. Siddiqui A A, Phillips T, Charest H, et al. Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4. Infect Immun, 2003, 71 (7): 3844-3851
17. Jankovic D, Wynn T A, Kullberg M C, et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell and IFN-γ-dependent effect mechanism. J Immunol, 1999, 162 (1): 345-351
18. Hoffman K F, James S L, Cheever A W, et al. Studies with double cytokine deficient mice reveal that highly polarized Th1 and Th2-type cytokine and antibody responses contribute equality to vaccine-induced immunity to Schistosoma mansoni. J Immunol, 1999, 163 (2): 927-938
19. Ayash-Rashkovsky M, Weisman Z, Zlotnikov S, et al. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile. Biochem Biophys Res Commun, 2001, 282 (5): 1169-1176